WDR64: A Potential Drug Target Or Biomarker for Various Diseases
WDR64: A Potential Drug Target Or Biomarker for Various Diseases
WDR64 (WDR64_HUMAN) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The gene is located on chromosome 16 and encodes a protein known as WDR64.
WDR64 is a transmembrane protein that plays a role in the regulation of cell growth, differentiation, and survival. It is expressed in various tissues and cells throughout the body, including the brain, spinal cord, and peripheral tissues.
Studies have shown that WDR64 is involved in a wide range of physiological processes, including cell signaling, cell adhesion, and cell survival. It has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
One of the key functions of WDR64 is its role in cell signaling. It is a negative regulator of the TGF-β pathway, which is a well-known pathway involved in cell growth, differentiation, and survival. This means that when WDR64 is activated, it works to inhibit the effects of TGF-β and prevent cells from growing and dividing out of control.
Another function of WDR64 is its role in cell adhesion. It is a critical regulator of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs. WDR64 has been shown to be involved in the regulation of cell-cell adhesion in various tissues and cells, including the brain and spinal cord.
In addition to its role in cell signaling and cell adhesion, WDR64 is also involved in the regulation of cell survival. It has been shown to play a key role in the regulation of cell cycle progression, which is the process by which cells grow and divide. This means that when WDR64 is activated, it works to control the length of the cell cycle and prevent cells from growing and dividing out of control.
The potential drug targets for WDR64 are numerous, and research is ongoing to determine just how it can be used to treat various diseases. One of the main targets for WDR64 is its role in the development and progression of cancer. Studies have shown that WDR64 is often expressed in various types of cancer, including breast cancer, lung cancer, and neurodegenerative disorders. This suggests that WDR64 may be a useful target for cancer treatments.
Another potential target for WDR64 is its role in neurodegenerative disorders. Studies have shown that WDR64 is often expressed in various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This suggests that WDR64 may be a useful target for neurodegenerative disorder treatments.
In addition to its potential as a cancer and neurodegenerative disorder treatment target, WDR64 may also be a useful biomarker for these diseases. Studies have shown thatWDR64 is often decreased in various types of cancer, including breast cancer, lung cancer, and neurodegenerative disorders. This suggests thatWDR64 may be a useful biomarker for monitoring the progress of these diseases.
Overall, WDR64 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to determine just how it can be used to treat these diseases and to develop safe and effective treatments.
Protein Name: WD Repeat Domain 64
The "WDR64 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR64 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1
